echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > Fengyuan biochemical "re-emerging rivers and lakes" amino acid industry pattern changes.

    Fengyuan biochemical "re-emerging rivers and lakes" amino acid industry pattern changes.

    • Last Update: 2020-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The "catfish" that had tried to stir up the biochemical and bio-new materials industries swam backpR9October 27th, a 30,000-ton-produced L-alanine production line will be put into production at Fengyuan Biomanufacturing Base in Anhui Province, and will be fully operational by the end of the year to meet the needs of more than 80% of the global marketpR9Securities Times.e company reporter was informed that the above-mentioned production line of the builders of Anhui Fengyuan Biochemistry Co., Ltd(hereinafter referred to as "Fengyuan Biochemical"), the company's controlling shareholder is Anhui Fengyuan GrouppR9"Fengyuan Biochemical" has disappeared for a long timeIn November 2006, COFCO group with 1 billion yuan in cash from Fengyuan Group to give the listed company Feng native control of the holding, and in 2011 it was renamed "COFCO Biochemicals." In 2016, Fengyuan Group re-registered "Anhui Fengyuan Biochemistry Co., Ltd.", a familiar biochemical industrypR9"currently is the key period of secondary entrepreneurship, domestic projects have entered the construction and operation phase", Fengyuan Group, an executive told the Securities Times.e company reporter, Fengyuan biochemical first phase of the project capital investment reached 1.5 billion yuan, in addition to alanine, an annual output of 150,000 tons of lysine and 30,000 tons of sucone production line will also be put into production this yearIn 2018, we will continue to expand the production of amino acid products, and new production lines of malic acid, lactic acid, amino acid and organic acid production plan to reach 500,000 tons / year, and will start the construction of a million tons of polylactic acid projectpR9combined with the current amino acid production and sales and operating rate, the new high-end production capacity of the abundance of nativeization will undoubtedly affect the existing market patternAnd Fengyuan Group Chairman Li Rongjie also plans to make "Nirvana Reborn" "Fengyuan Biochemical" to become the world's largest producer of bio-materials, back to the A-share marketpR9"disturbing" amino acid field pR9 old shareholders may remember the "Fengyuan system": at its peak Fengyuan Group's control of Fengyuan Pharmaceuticals, Fengyuan Biochemical (now "Cofco Biochemical") and Taifu Industrial (now "Shandong Mine") three listed platforms, and once provoked one of China's four major vitamin C raw material factory Jiangshan Pharmaceutical control battle At present, Li Rongjie through Galaxy Bio Holdings Fengyuan Group, and then control the listed company Fengyuan Pharmaceuticals, a stake in Shandong mining pR9 the first step of regaining the "golden signboard", Fengyuan biochemical fall stable, accurate, hard, first of all, selected the current fewer enterprises involved in the small varieties of amino acids - alanine Alanine can be used to synthesize food additives to improve taste and nutritional value, in the field of health care, is the basic raw material of synthetic vitamin B6, can also treat liver insufficiency caused by amino acid metabolism disorders In the japanese chemical industry, L-alanine as raw material, can be used to produce environmentally friendly performance of better surfactants pR9 Securities Times.e Company reporters obtained statistics show that last year, the global market demand for L-alanine was about 35,000 tons, half of which was used for the production of washing chemical supplies, and another 4000 tons as pharmaceutical raw materials for the production of VB6, amino propylene alcohol and so on On supply, Anhui Huaheng Bio, which is currently declaring an IPO, is ranked first in the world with a production capacity of 20,000 tons/year, and a few domestic enterprises such as Yantai Hengyuan have corresponding technology, and only Japanese enterprises such as Musashi wild, miso products, etc carry out alanine production on a scale, with production capacity below 10,000 tons pR9 in other words, The 30,000 tons/annual production line of Fengyuan Biochemicals, once fully operational, has been able to meet more than 85% of the global demand for alanine pR9 "alanine prices this year but market demand is not good, next year market demand will be good but the price will not be so good." Fengyuan Biochemical Chairman Fu Song frankly responded that, through the acquisition of the integration of Huaibei New Flag amino acids and independent research and development, and with the cooperation with domestic research institutes, the company has mastered the latest core technology in the field of alanine, coupled with a strong cost advantage, or drive the entire aalanine price downward adjustment next year pR9 Huaheng Bio IPO prospectus shows that last year the company's crude profit from the fermentation of glucose and ammonia could reach 33.16 percent Fengyuan biochemical said, relying on Fengyuan Group 1 million tons / year of corn deep processing capacity, according to the current production technology, with corn-converted glucose fermentation production, the cost of l-alanine in each ton of only glucose than peers can be reduced by 1000-1500 yuan / ton, the comprehensive cost is lower than the same industry 2000 yuan / ton pR9 dare to invest in huge capacity, but also from the demand side of the bullish It is reported that washing the chemical industry, coconut oil and L-alanine as raw materials of the surface active agent with non-toxic pollution-free characteristics, the world's major chemical giants in recent years are gradually adding l-alanine application, in the field of daily use of amino acid detergent to replace traditional washing products According to Fu Song, there have been a number of chemical enterprises to try Fengyuan biochemical Huaibei new flag alanine products pR9 are also being explored by other peers who are also moving slowly In mid-October this year, Hanye shares announced 28 million yuan from the Chinese Academy of Sciences to purchase l-alanine seed patented technology, committed to the realization of L-alanine industrial amplification production pR9 in addition to the new amino acids, due to product diversification and industry periodic considerations, Fengyuan biochemical will also produce traditional products including lysine, susine For example, at the end of 2016 by environmental pressure, transportation and other factors, lysine prices in the fourth quarter jumped to 15,000 / ton of the situation, a new high in nearly four years, has now fallen back to 8000-9000 yuan / ton of health market pR9 "how many enterprises open, how many enterprises close down", Fu Song believes that lysine, Susine and other traditional amino acid industries have not yet finally formed an "oligarchcompetition" situation, but the growth of new capacity slowed, backward production capacity phase-out speed, the industry still has the opportunity for squeezed development pR9 want to build a "global new materials base" pR9 the outside world, Fengyuan Group may not be relieved of that year's "pain cut love." Fengyuan Group, in conjunction with Tianjin University, Jiangnan University and the Chinese Academy of Sciences Plasma Institute, jointly funded the establishment of a national fermentation technology engineering research center, in organic acids, amino acids, vitamins and other bacteria, fermentation, separation and extraction technology continuousimprovement At present, the cost of manufacturing L-malic acid by Fengyuan biochemical fermentation method can match the traditional citric acid products, and is expected to replace part of the citric acid market with better taste pR9 in addition to the force of amino acids, organic acids, Fengyuan biochemical desire to win a larger vision is: the use of high-tech transformation of traditional biological industry, to build the world's largest base of bio-new materials pR9 in fact, The Fonyuan Group has been concerned with the lactic acid and polylactic acid industries for more than 15 years In 2002, Fengyuan Biochemical (Cofco Biochemical) and The Belgian Gratt co-invested in the establishment of the Asia-Pacific region's largest lactic acid production enterprise Stonic Grat (Cofco Biochemical Grat) In COFCO's semi-annual report this year shows that the lactic acid industry as a whole is flat, production capacity oversupply pR9 the polymeric material polylactic acid formed by lactic acid polymerization is a new industry, with environmental protection, non-toxic, antibacterial, flame retardant and biodegradable advantages, is considered to be the most promising future to shake the traditional status of petroleum-based plastics and chemical fiber bio-new materials Data show that in recent years, the market and production scale of polylactic acid industry are growing at a rate of 25-35%, the end of 2016 the overall domestic production capacity of about 70,000 tons pR9 to now, the new Fengyuan biochemical has begun to lay out the whole industrial chain processing line of corn-lactic acid-polylactic acid, and will later build an annual output of 1.5 million tons of lactic acid and 1 million tons of polylactic acid production line, more than Cargill and Dow Chemical joint venture set up the global polylactic acid leading company NatureWorks pR9 "downstream application problems can be solved, only dare to such a large capacity project", this is Fengyuan biochemical research and development personnel to the reporter's introduction, from 2015, Fengyuan Group on the establishment of a professional team to solve the downstream application problem Securities Times reporter at the scene saw that the current Fengyuan biochemical plant has been trialed out of T-shirts, socks, non-woven snout, plastic bags and biodegradable plastic tableware, some polylactic acid textile fabrics have been supplied to the Jiangsu and Zhejiang region of the garment factory trial pR9 future Fengyuan does not plan to produce these end products, according to Fengyuan biochemical research and development personnel, they are studying the application of polylactic acid fiber in cigarette filters, followed by color weaving, agricultural film and other fields to further explore According to statistics, China only polyester, spandex, acrylic and other oil-made synthetic fiber textile fabrics, a year of oil consumption of more than 70 million tons, if in the textile field can popularize polylactic acid fiber, its green environmental protection can be seen pR9 in the future, China will vigorously develop fuel ethanol, polylactic acid and other bio-energy and bio-new materials products, the market size will reach 10 million tons scale According to the Development and Reform Commission's "13th Five-Year Plan" bio-industry development plan, will vigorously promote the large-scale application of biomanufacturing, improve the innovation and development capacity of the bio-manufacturing industry, promote the large-scale production and application of bio-based materials, bio-based chemicals, new fermentation products, etc., by 2020, the output value of modern bio-manufacturing industry exceeds 1 trillion yuan, bio-based products in the total chemical production of 25%, compared with traditional routes, energy consumption and pollutant emissions reduction of 30%, for China's economic and social development pR9 although the industry has been bullish, higher raw material costs and energy consumption, as well as complex polymerization processes, determine the high cost of polylactic acid However, Fu Song said that After 15 years of continuous research and development, Fengyuan in 2016 in the key technology of polylactic acid made a major breakthrough, fully mastered the production of polylactic acid from the production of polylactic acid fermentation, extraction and polymerization technology, as well as the production of polylactic acid fiber and plastic products of the whole industrial chain production technology, and significantly reduce the production cost of polylactic acid, polylactic acid cost to 15,000 yuan / ton, can be close to the corresponding cost of petroleum-based chemical fiber and plastic, with the promotion of conditions pR9 Securities Times reporter learned that Fengyuan biochemical plan as soon as possible to replicate polylactic acid production capacity, in 5 years to reach 1 million tons / year of production The company will also rely on the global industrial layout of Fengyuan Group, in the agricultural products rich in the region to build production bases, according to market promotion, rapidly improve polylactic acid production capacity, planning within 10 years production of 10 million tons / year, by 2030, polylactic acid production will reach 30 million tons / year pR9 "We are building an upgraded version of The 'Fengyuan Biochemical' and hope to reunite in the capital markets as soon as possible, " Fu said At present, Fengyuan Group has four business sectors: vitamins, organic acids, amino acids and pharmaceutical chemical raw materials-based domestic manufacturing enterprises, biofermentation and pharmaceutical research and development platform, overseas agricultural products deep processing industry and import and export trade business, of which Fengpronative and Tiger Biology, will become the group's sprint IPO first echelon pR9 the "catfish" that tried to stir up the biochemical and bio-new materials industries, and swam back pR9 October 27th, a 30,000-ton-produced L-alanine production line will be put into production at Fengyuan Biomanufacturing Base in Anhui Province, and will be fully operational by the end of the year to meet the needs of more than 80% of the global market pR9 Securities Times.e company reporter was informed that the above-mentioned production line of the builders of Anhui Fengyuan Biochemistry Co., Ltd (hereinafter referred to as "Fengyuan Biochemical"), the company's controlling shareholder is Anhui Fengyuan Group pR9 "Fengyuan Biochemical" has disappeared for a long time In November 2006, COFCO group with 1 billion yuan in cash from Fengyuan Group to give the listed company Feng native control of the holding, and in 2011 it was renamed "COFCO Biochemicals." In 2016, Fengyuan Group re-registered "Anhui Fengyuan Biochemistry Co., Ltd.", a familiar biochemical industry pR9 "currently is the key period of secondary entrepreneurship, domestic projects have entered the construction and operation phase", Fengyuan Group, an executive told the Securities Times.e company reporter, Fengyuan biochemical first phase of the project capital investment reached 1.5 billion yuan, in addition to alanine, an annual output of 150,000 tons of lysine and 30,000 tons of sucone production line will also be put into production this year In 2018, we will continue to expand the production of amino acid products, and new production lines of malic acid, lactic acid, amino acid and organic acid production plan to reach 500,000 tons / year, and will start the construction of a million tons of polylactic acid project pR9 combined with the current amino acid production and sales and operating rate, the new high-end production capacity of the abundance of nativeization will undoubtedly affect the existing market pattern And Fengyuan Group Chairman Li Rongjie also plans to make "Nirvana Reborn" "Fengyuan Biochemical" to become the world's largest producer of bio-materials, back to the A-share market pR9 "disturbing" amino acid field pR9 old shareholders may remember the "Fengyuan system": at its peak Fengyuan Group's control of Fengyuan Pharmaceuticals, Fengyuan Biochemical (now "Cofco Biochemical") and Taifu Industrial (now "Shandong Mine") three listed platforms, and once provoked one of China's four major vitamin C raw material factory Jiangshan Pharmaceutical control battle At present, Li Rongjie through Galaxy Bio Holdings Fengyuan Group, and then control the listed company Fengyuan Pharmaceuticals, a stake in Shandong mining pR9 the first step of regaining the "golden signboard", Fengyuan biochemical fall stable, accurate, hard, first of all, selected the current fewer enterprises involved in the small varieties of amino acids - alanine Alanine can be used to synthesize food additives to improve taste and nutritional value, in the field of health care, is the basic raw material of synthetic vitamin B6, can also treat liver insufficiency caused by amino acid metabolism disorders In the japanese chemical industry, L-alanine as raw material, can be used to produce environmentally friendly performance of better surfactants pR9 Securities Times.e Company reporters obtained statistics show that last year, the global market demand for L-alanine was about 35,000 tons, half of which was used for the production of washing chemical supplies, and another 4000 tons as pharmaceutical raw materials for the production of VB6, amino propylene alcohol and so on On supply, Anhui Huaheng Bio, which is currently declaring an IPO, is ranked first in the world with a production capacity of 20,000 tons/year, and a few domestic enterprises such as Yantai Hengyuan have corresponding technology, and only Japanese enterprises such as Musashi wild, miso products, etc carry out alanine production on a scale, with production capacity below 10,000 tons pR9 in other words, The 30,000 tons/annual production line of Fengyuan Biochemicals, once fully operational, has been able to meet more than 85% of the global demand for alanine pR9 "alanine prices this year but market demand is not good, next year market demand will be good but the price will not be so good." Fengyuan Biochemical Chairman Fu Song frankly responded that, through the acquisition of the integration of Huaibei New Flag amino acids and independent research and development, and with the cooperation with domestic research institutes, the company has mastered the latest core technology in the field of alanine, coupled with a strong cost advantage, or drive the entire aalanine price downward adjustment next year pR9 Huaheng Bio IPO prospectus shows that
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.